News
Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first autologous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback